INTRODUCTION
In their unliganded form, steroid receptors from cytosolic extracts are complexed in large inactive heterooligomeric structures with several receptor-associated proteins (see Ref. 1 for a review). Among these proteins, two have been identified as heat shock proteins (hsps) namely hsp90 1 (2) (3) (4) , and hsp70 (5, 6) . Other receptor-associated proteins belong to a class of peptidyl-prolyl isomerases, termed immunophilins (7): two FK506-binding proteins, FKBP52 (8) (9) (10) (11) , which migrates at 59 kDa in denaturing gel electrophoresis and therefore was initially called p59 (12) , and FKBP51 (13, 14) , previously named FKBP54 (15) . In addition to these FKBPs, a cyclosporin A (CsA)-binding protein of 40 kDa, cyclophilin 40 (CYP40) (16, 17) was characterized. These immunophilins, FKBP51 and FKBP52, as well as CYP40, bind at the same site on hsp90 (Refs. 14, 18; see Ref. 1 for a review). CYP40, FKBP51, and FKBP52 were the first of the cyclophilin and FKBP classes of immunophilins found to possess C-terminal amino acid sequence identities (10, 11, (13) (14) (15) (16) (17) in the form of three tetratricopeptide repeat units required for binding to hsp90 (19) . The association of FKBP52, FKBP51, and CYP40 with hsp90 was demonstrated by coimmunoprecipitation (8, 12, (14) (15) (16) (20) (21) (22) (23) , native gel electrophoresis (19) , cross-linking (20, 21) , and immunosuppressant-affinity chromatography (14) (15) (16) (17) (18) (22) (23) (24) experiments. Therefore, FKBP52, FKBP51, and CYP40 may represent the first members of a new class of peptidyl-prolyl isomerases, the heat shock protein binding immunophilins (25) . They all exist in independent heterocomplexes with hsp 90 (14, 18, 24) , in association with other proteins thought to participate in the folding process of the receptor (see Ref. 1 
for a review).
Hsp70 has also been shown to be part of heterooligomeric complexes containing hsp90 and FKBP52 that are associated with the PR in human breast cancer T47D cells (26, 27) . In fact, large molecular chaperone complexes including FKBP52, FKBP51, hsp90 and, in some cases, hsp70 seem to exist in many cells. Up to now, these receptorassociated immunophilins are thought to be involved in a molecular chaperone mechanism, and although it has been recently proposed that FKBP 52 could serve as a mediator of dexamethasone (Dex)-induced glucocorticosteroid (GR) trafficking (28), their targets in the receptor complex(es) are still not well identified.
Recent studies have suggested that FKBPs and cyclophilins modulate Dex-induced transcription in mouse fibroblasts since immunosuppressants potentiate steroid-induced transcription in these cells (24, 29) . Similarly, FK506 potentiates progestin-induced transcription in yeast strains transfected with human PR B form (30). This potentiation was shown recently to be the consequence of the reversal activity of a membrane efflux mechanism resembling, but different, from that of phospho-glycoprotein, P-gp (31-33). Then, at least in mouse fibroblasts and in yeast, it is obvious that the targets of the effects of immunosuppressants on steroid actions could not explain the observed cellular responses.
In this work, we used two lines derived from T47D cells, known to express high levels of PR (34), to study the effects of immunosuppressants on steroidinduced transcription. The lines contained stably transfected plasmids encoding CAT reporter genes under control of the mouse mammary tumor virus long terminal repeat (MMTV-CAT) (35) or the synthetic steroid-inducible minimal promoter GRE 5 (GRE 5 tkCAT) (36). In the two T47D cell lines, Rap and FK506, but not CsA, inhibited progestin-, as well as triamcinolone acetonide (TA)-, induced transcription. This occurred at a step preceding steroid-induced receptor activa- 1 Abbreviations used are: hsp90, heat shock protein of molecular mass 90 kDa; hsp70, heat shock protein of molecular mass 70 kDa; FKBP, FK506 binding protein; FKBP51, FK506-binding protein of apparent molecular mass 54 kDa; FKBP52, FK506-binding protein of apparent molecular mass 59 kDa; CYP40, cyclophilin of molecular mass 40 kDa; R5020, promegestone, 17␣,21-dimethyl-19-norpregna-4,9-diene-3,20 one [17␣ methyl-3 H]; [ 3 H] Org2058, 16a-ethyl-21-hydroxy-19-nor [6,7- 3 H]-pregn-4-ene-3,20-dione; RU486, mifepristone, 11␤-(4-dimethyl-aminophenyl)-17b-hydroxy17a-(prog-1-ynyl) estra-4,9-dien-3-one; dexamethasone, (11␤, tion. 2 Similar inhibiting activity by Rap was also observed on progestin-induced Cyclin D1 mRNA levels, a progestin-regulated gene (37, 38).
Numerous works have established that immunophilins play a role in cell-signaling pathways involving phosphorylation (Ref. 39 for a review). Since we had previously found that rabbit uterus FKBP52 copurifies with either a Mg 2ϩ or a calcium-calmodulin dependent kinase (CaMK) (40), and since two CaMK consensus sequences are present in FKBP52 (10, 11) and FKBP51 (14, 41) , we tested the effect of CaMK inhibitors on steroid-induced transcription. The two CaMK inhibitors, KN62 and KN93, inhibited the steroid-induced transcription in both cell lines, at a step upstream to steroid-induced receptor activation; in addition, Rap and KN62 inhibited progestin-induced expression of Cyclin D1 mRNA. This suggests that a CaMK phosphorylation/dephosphorylation-mediated mechanism regulates steroidinduced transactivation before the steroid-induced dissociation of receptor-associated hsps/FKBP complexes from the receptor, that immunosuppressant ligands for FKBPs 51 and 52 act at a step preceeding such a dissociation process, and that two exogenous and endogenous genes are similarly regulated by Rap and by CaMKs.
RESULTS

Inhibition by Rap and FK506 of ProgestinInduced Transcription in T47D(MMTV-CAT) Cells
The maximal induction of CAT activity in T47D (MMTV-CAT) cells (ϳ 200 fold that of the basal level) occurred at 100 nM R5020 (Fig. 1A) . When cells were preincubated with a single concentration (10 M) of Rap, before addition of a range of R5020 concentrations, an inhibition of CAT activity was observed (Fig. 1A) . FK506 was a weaker inhibitor than Rap, and CsA did not seem to affect CAT gene expression. At low R5020 concentrations, a dose-dependent inhibition by Rap and FK506 was obtained (Fig. 1B) . The inhibitory effect of Rap appeared more pronounced than that obtained with FK506. CsA had no significant inhibitory effect on CAT activity even when used at 10 M (Fig. 1B) . None of the drugs had any effect on CAT activity when used alone (not shown). A similar inhibitory effect of Rap was obtained, whether the immunosuppressant was added before or at the same time as the progestin (Fig.  1B ). All these effects were abolished by a 100-fold excess of the antiprogestin RU486 (not shown), indicating that induction of CAT activity is mediated by the PR.
Effect of Immunosuppressants on ProgestinInduced Transcription in T47D (GRE5-CAT) Cells
In T47D-GRE 5 -CAT cells, the maximum CAT activity (ϳ200 times that of the basal level) was obtained for ϳ3 nM R5020 (36) or 0.3 nM Org 2058 (not shown). Figure 2 shows that, similar to T47D MMTV CAT cells, A, Cells were exposed as indicated for 2 h to 10 M of immunosuppressants, followed by the indicated concentrations of R5020 for 16 h. CAT activity was calculated relative to the basal activity measured in the absence of steroid. The results are the mean values for at least three determinations in duplicate. B, Cells were exposed to the indicated concentrations of immunosuppressants then to 0.1 nM (filled bars) or 1 nM (open bars) R5020. CAT activity was measured as in Fig. lA . The CAT activity calculated for each drug concentration is the result of a decreased activated level of CAT and not that of an increased background. Control experiments with only 0.1 and 1 nM R5020 alone are shown (bars, C). Similar results were obtained when drugs and steroid were added at the same time.
Rap strongly inhibited progestin-induced transcription, in a dose-dependent manner. Once again, Rap was more efficient than FK506 and CsA had no effect. Addition of a 100-fold molar excess of RU486 blocked progestin-inducible CAT activity (not shown), strongly suggesting that the observed gene expression in both cell lines is mediated by the PR.
Effect of Immunosuppressants on Glucocorticosteroid-Induced Transcription
In the cell line T47D (GRE 5 )-CAT, TA induced transcription in a dose-dependent manner (Fig. 3A) . The maximal induction of CAT activity occurred at 10 nM. This maximum reached almost 150-fold that of the basal level and was inhibited by RU486 (not shown). Figure 3B shows that exposure of cells to Rap or FK506 provoked a decreased response to either 1 or 10 nM TA. CsA, on the other hand, did not affect TA-induced CAT activity. Figure  4A shows that KN62 decreased R5020-induced transcription in a dose-dependent manner in both T47D cell lines. Similarly, KN62 also inhibited TA-induced transcription in T47D (GRE 5) -CAT (Fig. 4B) , as well as in T47D (MMTV)-CAT (not shown). KN93 inhibited both R5020-and TA-induced CAT activity in both cell lines but at a 2-to 3-fold lower concentration than KN62 iself (Fig. 4C) . This difference may reflect the greater water solubility of KN93 (44) . These results suggest that a CaMK activity is involved in the steroid-induced activation of either PR and GR and that its inhibition decreases steroid-induced transcription in T47D cells.
Effect of
Effects of Rap and KN62 after Exposure of Cells to Steroids
All the experiments described above were performed by adding drugs (immunosuppressants or CaMK inhibitors) before steroids in cell culture medium. 
Effects of Immunosuppressants and CaMK Inhibitors on Progestin-Induced mRNA Synthesis
The mRNA encoding cyclin D1 is one of many transcripts whose levels are increased in T47D cells in the presence of progestin (37, 38). We analyzed the influence of immunosuppressants and KN62 on cyclin D1 mRNA level. Rap, FK506, or KN62 had no individual effect on the abundance of Cyclin D1 transcripts. By contrast, Rap and KN62 stongly inhibited the R5020-induced increase of Cyclin D1 mRNA, while FK506 had a weaker effect (Fig. 6) .
In a control experiment, the mRNA level of the ubiquitous non-progestin-regulated GAPDH was not modified by any of the drugs tested under these conditions. These results would indicate that Rap, FK506, and KN62, but not CsA, down-regulate the progestininduced transcription of the endogenous Cyclin D1 gene.
Effects of Rap and KN62 on the Heterooligomeric Forms of PR and GR
Given the drug effects reported above, we next sought to investigate whether stabilization of an inactive non-DNA-binding form of steroid receptors could be responsible for these effects. In the absence of hor- mone, PR is located in the cell nuclei, from which it can be recovered in the low-salt cytosoluble fraction of cellular homogenates. Under these conditions, PR can be postlabeled with 3 H-labeled ligands, and ligand/PR complexes migrate at 9S in density gradients. They contain PR hormone-binding units, hsp(s), and immunophilin(s). In vivo, after exposure to hormone, the PR is tightly bound to nuclei and can be extracted by high salt-containing buffers (Ͼ0.4 M NaCl), giving rise to 4-5S complexes that are free of receptor-associated proteins (see Ref. 1 for a review). Molybdate ions have been widely shown to protect 9S species from the in vitro transformation into 4-5S species induced by high salt. We have found that tungstate oxyanions are more efficient than molybdate in preventing such a saltinduced transformation (20, 45) . In the presence of tungstate, 9S nuclear [ 3 H]RU 486-PR species were recovered in which hsp90 and FKBP52 still remained associated with the PR units (45) . Here, we analyzed tungstate-stabilized complexes extracted from cells treated with Rap. T47D cells were exposed to 10 M Rap in the presence of 10 nM These results indicate that Rap would act as a stabilizer of the 9S species (Fig. 7C ). Numerous studies from many laboratories have established that the 9S form of PR represents a combination of complexes of the hormone binding B and A PR forms associated with the molecular chaperone hsp90 and FKBPs (review in Ref. 1). In addition, the unliganded rabbit uterus 9S-PR has been shown to be stabilized in vitro by FK506 and Rap (22) . Similarly, the untransformed GR complex from S49 lymphocytes was also stabilized in vitro by FK506 (46) and did not interact with nonspecific DNA, consistent with the behavior of the GR compatible with the presence of GR in complexes with associated hsp(s) and immunophilin(s). We conclude from experiments of Fig. 7 that Rap may act in T47D cells by impairing the agonist-induced release of molecular chaperones from the PR. In contrast, KN93 itself does not stabilize the PR and seems to act differently than Rap (Fig. 7D ).
Protein Composition of PR Heterocomplexes from T47D Cells
Immunoprecipitation experiments were used to identify the different proteins present in PR heterocomplexes. Cytosol from T47D-(GRE 5 ( Fig. 8A ). When immunoprecipitation was performed with the anti-FKBP52 EC1 antibody, 20% of the initial PR binding was immunoprecipitated. No radioactivity was recovered in immunoprecipitates of similar experiments performed with either the anti-CYP40 638W antibody or with the anti-FKBP51 HI51 antibody, or with control nonimmune rabbit or mouse antibodies. This suggested that PR-B was absent from immunopellets. This was confirmed by Western blot experiments (Fig. 8B) . The PR-B form was detected in the mPRI and in the EC1 immunopellets, along with hsp90 and hsp70, arguing for the presence of cytosolic complexes including PR-B, hsp90, hsp70, and FKBP52 in T47D cells. Neither the PR-B form nor hsp70 was detected in the 638W immunopellets, whereas CYP40 and hsp90 were readily detected. This indicates that CYP40 is neither associated with PR-B nor with hsp70 in T47D cells cytosol. Western blot analysis with MA1-140 antibody of 638 W immunopellets did not detect PR-B or PR-A (not shown), confirming that no PR is associated with CYP40 in cytosol of T47D cells. Similarly, FKBP51 was not associated with PR either in mPRI or HI51 immunopellets, but it coprecipitated with hsp90.
FK506-and CsA-Affigel Affinity Chromatography
Data from Fig. 8 suggested that PR from T47D associates with only one immunophilin-hsp complex. This may appear to contrast with early published results (14) , indicating a preferential association of PR with FKBP51 in a cell-free reconstitution system (14) . Therefore, we checked for the protein composition of PR from T47D cells exposed to immunosuppressants or to PR ligands or to both, by FK506 and CsA affinity chromatography, performed as described in Materials (Fig. 9, upper panel) , but not from the CsA-Affigel or the non-grafted control Affigel 10 columns. Western blot experiments (Fig. 9 , A-E) confirmed these results, as no PR-A and PR-B forms were detected in the CsA eluate from the CsA-Affigel column. In contrast, both PR forms were detectable in the FK506 eluate from FK506-Affigel (see lane 4 in Fig.  9A ). In addition, FKBP52 was almost totally retained on the FK506-Affigel resin and eluted as a doublet, concomitantly with hsp90 and hsp70, as revealed by Western blot using EC1 and 174 antibodies, respectively (Fig. 9, A and C, left panels, lane 4) .
Similarly, CYP40 and hsp90 coeluted from the CsAAffigel column (Fig. 9C, right panel, lane 4) . Since no radioactivity or immunoreactive PR were found in the CsA eluates, we concluded that PR from T47D cells is not associated with CYP40, or that high-salt exposure provoked dissociation of CYP40 from the PR-hsp90-CYP40 complex. However, both FKBP52 and CYP40 were found associated with hsp90, and exposure to immunosuppressant did not disrupt this association. Confirming the results of Fig. 8, hsp70 was not found to be associated with CYP40, (Fig. 9 , panel C, right, lane 4). FKBP52, PR-A, PR-B, hsp90, and CYP40 were all found in the flowthrough of the control Affigel-10 column (Fig. 9, B and D, lane 1) , none of them being detectable in the eluates (Fig. 9, B and D, lane 4) . FKBP51 was eluted from FK506-Affigel resin, loaded with unlabeled-PR containing cytosol concomitantly with both PR-A and PR-B (Fig. 9 , right part of panel E). Similar experiment performed with cytosol containing [ 3 H]RU486-PR complexes, revealed that FKBP51 did not coeluted with PR from the FK506 column; both forms of PR were found in the flowthrough fraction (Fig. 9, left panel) . Some FKBP51 did not bind to the resin possibly due to overloading of the column and/or to loading conditions using buffer containing low salt concentration; FKBP51 binds in fact, better to FK506 in high salt rather than in low salt buffers (15) , but to maintain as much as possible the integrity of the heterocomplex(es) which dissociate in high salt (1, 5, 6, 20) , we chose to add 0.15 M NaCl in loading buffer as a compromise. These data, along T47D (GRE5) CAT cells were grown to 50% confluence in T150 flasks in DMEM supplemented with 10% FCS. The medium was then replaced by DMEM without serum for 48 h, followed by DMEM supplemented with 10% stripped and heat-inactivated serum containing or not (control) 10 M of the indicated drugs for 2 h; then 10 nM R5020 was added for 16 h to the culture medium. RNA was isolated with Trizol reagent, and Northern analysis was performed to determine Cyclin D1 and GAPDH expression as described in Materials and Methods. Typical GAPDH signals were achieved after 24 h of autoradiography, and Cyclin D1 signals were achieved after 72 h of autoradiography (panel A). Using densitometric analysis, GAPDH was used to normalize for variations in signal intensity. The autoradiogram shown was typical of three Northern blots.
with those shown in Fig. 7 , support the concept that hormone-binding to PR induces FKBP51 release from the heterocomplex, in agreement with previous report from Smith et al. (15) .
Identical experiments were performed with cytosol from T47D (GRE 5 ) CAT cells, in which the GR had been labeled with [ 3 H]TA. In this case, [ 3 H]TAGR-hsp90-FKBP52 and unlabeled GR-hsp90-FKBP51 complexes were characterized after the same western blot technique as that described in Fig. 9 . TA binding to the GR, like progestin binding to the PR, induced a release of FKBP51 from the receptor heterocomplex (not shown). Similar to the PR, the GR was not found associated with the CYP40-hs90 complex (not shown). Altogether, these results indicate the presence of PR and GR in different molecular chaperone complexes, including always hsps plus cochaperones such as FKBP51 and FKBP52 but not CYP40. (panel E). By contrast, no FKBP and no hsp coimmunoprecipitated with PR when cells were exposed to progestin alone, to CsA plus progestin or to KN62 plus progestin. These results supported the results obtained in Fig. 7 , which suggested that Rap, but not KN62, may stabilize the FKBP52-hsp90-PR complex. In contrast, Rap did not stabilize a FKBP51-hsp90-PR complex which appeared to dissociate after steroid binding to the PR.
Stabilization of FKBP52-(hsp90-PR) Complex by Rapamycin in Cells Exposed to PR Ligands
DISCUSSION
In previous reports, immunosuppressive drugs such as FKBP's (FK506 and rapamycin) and cyclophilin ligands (CsA and analogs) were shown to potentiate the Dex-induced expression of the MMTV-CAT reporter gene (24, 29) in a stably transfected mouse fibroblast LMCAT cell line, (29). This potentiation was demonstrated to be the consequence of the reversal by im- . After cells were harvested, cytosols and nuclear extracts were prepared as described in Materials and Methods in a buffer containing always 20 mM sodium tungstate ions to maintain the heterooligomeric PR structure. Samples from cells not exposed to drugs and steroid (panel A) were incubated for 4 h at 0 C with 10 nM [ 3 H]Org2058 and treated with a dextran-coated charcoal suspension as described in Ref. 47 , before loading on top of preformed gradients. Aliquots (100 l) of both cytosol (OE O OE ) and nuclear extracts (F O F) were loaded on 5-20% sucrose preformed gradients in buffer A containing 20 mM tungstate ions and ultracentrifuged as described in Materials and Methods. Positions of internal standards GO (7.9)s and PO (3.6)s are indicated.
munosuppressants of an efflux membrane mechanism resembling P-gp(s) which led to increased intracellular steroid concentrations in yeast (31, 32), and in mouse fibroblasts (33). These observations called into question any role of receptor-bound immunophilins in steroid-induced gene transactivation. In this study, we observed that two human T47D breast cancer cell lines, stably transfected with the same promoter/ reporter construct MMTV-CAT (35) or a GRE 5 -CAT reporter (36), respond differently from LMCAT cells when exposed to immunosuppressants. In fact, instead of a potentiation of the steroid-induced transcription, an inhibition of glucocorticosteroid and progestin-induced CAT activity was observed after exposure of T47D cells to Rap or FK506 (Figs. 1-3 ). This effect was also observed with the endogenous Cyclin D1 gene. All glucocorticosteroid-and progestin-inducible gene expression observed in these lines was inhibited by RU486, supporting a direct role of the GR and the PR. By contrast, no change in the expression level of GAPDH transcripts, a non-steroid-regulated gene was observed in the presence of Rap, FK506 and KN62. The effect of Rap correlated with a stabilization of 9S receptor-associated complex(es), strong suggesting the observed inhibition is not due to modulation of P-gp activity. In addition, results obtained with T47D GRE 5 CAT cells led us to conclude that the inhibition of steroid-induced transcription by (1 l/ml); hsp90 and hsp70 were revealed by 174 (1:6000); FKBP52 was revealed by 173 (1:10000); the rabbit anti C-terminal anti-FKBP52 was used to avoid recognition of the heavy chains of mouse IgGs that occurs when MPRI, mouse nonimmune (mouse n.i.), and EC 1 antibodies are used. FF1 (2 g/ml) was used to detect FKBP51, and 638W (1:6000) was used to detect CYP40. The ECL chemiluminescent technique was employed. immunosuppressants involves recruitment of transcription factors specific for GRE/PRE sequences and not those specific to other sequences present in the MMTV promoter. Moreover, no changes in levels of PR or GR, or their affinities for hormone was observed in drug-treated cells (S. LeBihan, unpublished results).
In T lymphocytes, a number of genes was reported to be inhibited by immunosuppressants (39, 42). In contrast, in non lymphoid cells, only a few genes were affected, such as a cAMP-responsive element (CRE)-regulated gene (48) , the PRL promoter (49) and the gene coding for the orphan steroid receptor NUR77 (50) . In these cases, an inhibition of transactivation by immunosuppressive drugs was observed which was suggested to involve the smaller forms of immunophilins, FKBP12 and CYP18 (51, 52) . The inhibition occurred at drug concentration at least 100-fold smaller than those necessary to inhibit CAT activity in the studies presented here. In all cells, the common feature of CYP18-CsA and FKBP12-FK506 complexes is binding and inhibiting CN protein phosphatase activity (53, 54) . In contrast, the FKBP12-rapamycin complex does not block CN activity (Ref. 42 , for a review) but interrupts, although indirectly, the activation of the 70-kDa S6 kinase (55, 56) and p34 cdc2 kinase activity in vivo (57) . These observations provide a mechanism for cell cycle arrest by Rap. More recently, the mammalian target of Rap-FKBP12 complexes was identified as a 280-kDa molecular mass protein (58) (59) (60) homologous to the yeast product of TOR2 gene, which has phosphatidylinositol kinase activity (61) . However, this kinase activity is not directly inhibited by binding of Rap to FKBP12. Rather, it was suggested that Rap interferes with the association or phosphorylation of a G1 effector (62) . All these findings indicate that immunosuppressant-immunophilin complexes play a role in cell-signaling pathways involving phosphorylation of a number of substrates. It is therefore tempting to speculate that, by analogy, receptor-associated immunophilins could influence the phophorylation of one or several proteins of the receptor heterocomplexes or may act upon effectors of some phosphorylation/dephosphorylarion process involved in steroid receptormediated signaling.
To test this hypothesis, we analyzed the effects of different kinase inhibitors on receptor signaling. We found that wortmannin, an inhibitor of PI3 and PI4 kinases, as well as the protein kinase A inhibitor H89, did not modify either progestin-and glucocorticosteroid-induced CAT gene activity in the two cell lines studied (not shown). However, KN62 and KN93, specific inhibitors of Ca 2ϩ /CaM-dependent kinases of type II and of type IV, inhibited both progestin-and glucocorticosteroid-induced transcription in a dose- An experiment identical to that described in Fig. 7 was performed, and whole cell extracts (250 l) were immunoprecipitated with 100 l protein G Sepharose to which 20 g MA1 140 anti-PR antibody had been covalently cross-linked by the method described in Ref. 74 ; immunoprecipitated proteins were eluted at elevated pH as described in Materials and Methods. After 10% SDS-PAGE, antigens were probed with the following antibodies: mPR1, for detection of PR B (panel A), 174 for detection of hsp90 and hsp70 (panel B), EC1 for detection of FKBP52 (panel C), FFI for detection of FKBP51 (panel D), and 638W for detection of CYP40 (panel E). Each lane in each panel contains 40 l of eluted proteins: 1, immunoprecipitate from control cells not exposed to steroid and drug; 2, immunoprecipitate from cells exposed to 10 nM [ 3 H]Org2058; 3, immunoprecipitate from cells exposed to 10 M Rap and then to radioactive progestin; 4, immunoprecipitate from cells exposed to 10 M KN62 and then to radioactive progestin; 5, immunoprecipitate from cells exposed to 10 M CsA and then to 10 nM [ dependent manner (Fig. 4) . This may indicate that phosphorylation by a CaMK is a process that can modulate steroid receptor-mediated gene expression. This is compatible with the observed generation of GR-hsp 90 complexes incapable of binding hormone after in vivo treatment of LMCAT cells with Calmodulin antagonists (63) . It is not known whether Rap or FK506, which also inhibits steroid-induced transcription in T47D cells, block the activity of CaMKs of type II and of type IV.
It is interesting to note that these CaMK inhibitors potentiated Dex-induced expression of the CAT gene in LMCAT cells similarly to the effects of immunosuppressants in these cells (64) . Thus, the effects of CaMK inhibitors and immunosuppressants with regard to steroid-induced transcription appeared strictly parallel in different cell types. CaMK inhibitors were shown to affect the Ca 2ϩ regulation of several immediate early genes such as NUR77 (50), supporting the concept of a broad role for CaMKs in transcriptional regulation. We have also shown that FKBP52 is a delayed early gene (65) . It is therefore possible that a decrease of FKBP52 gene expression, which could result from CaMK inhibition, could induce a repression of steroidinduced gene transcription. Whether steroid-induced gene expression inhibited by Rap or other immunosuppressants or whether effects of CaMK inhibitors are interrelated remains to be established. But it is likely that both kinds of drugs affect pathways modulating the activity of (a) common factor(s). Such a hypothesis is consistent with the experiments of Figs. 5 and 7, which indicated that immunosuppressants and CaMK inhibitors act 1) before steroid-induced receptor activation and 2) by apparently two different pathways, since only Rap but not KN62 stabilizes the PR (and the GR) heterooligomer.
In fact, unliganded PR and GR from T47D cells are contained in different heterocomplexes including immunophilins and hsps like PR and GR from other cells and/or tissues ( Ref. 1 for review) . Obviously, from the data of Fig. 9 , the PR from T47D cells eluted from FK506-affinity chromatography and coimmunoprecipitated with FKBP51 anf FKBP52, both associated with hsp90 in separate complexes, but not with CYP40. However,CYP40 is present in T47D cell cytosol, associated with hsp90 similar to other cell types such as mouse fibroblasts (24) and lymphoids (63) . Such an observation had been already made by Milad et al. (66) in T47D B11 subline stably transfected with the MMTV-CAT construct (67) . In this subline, CYP40 did not coimmunopurify with PR, whereas CsA potentiated R5020-induced CAT activity. Surprisingly, Rap and FK506 had no effect and FKBP52 coimmunoprecipitated with PR (66) , results that are the opposite of those obtained here. Thus, it is possible that specific cellular factors are recruited in hormone-induced transactivation of transfected exogenous genes, the level of expression of which may be quite different, as well as their integration at the chromatin level from one cell line to another one.
The targets of CaMK inhibitors in steroid-regulated gene transcription are not known. Like immunosuppressants Rap and FK506, they act before the ligand binding-induced conformational change of the receptors, which conducts to the release of receptor-associated hsp-90/immunophilins complexes. PR-and GR-FKBP52-hsp90 complexes have been shown to be stabilized by immunosuppressant binding (22, 46) . In addition, the phosphorylation of FKBP52 by casein kinase II inhibits its binding to hsp90 (68) . This suggests that interactions between the components of molecular chaperone complexes involved in steroid receptor regulation are likely controlled by a phosphorylation/dephosphorylation mechanism. It is quite possible that both CKII and CaMKs II or IV may intervene directly or not, in both the maturation of steroid receptors and the steroid receptor-mediated transactivation processes. Steroid receptors are known to be influenced by different signaling pathways such as cAMP, insulin-like growth factor-I, and kinase(s) and/or phosphatase(s) inhibitors (69) (70) (71) (72) . In addition to their immunosuppressive activity, FK506, Rap, and CsA (as well as some of their analogs), cause a variety of effects not only at the membrane level but also in calcium mobilization and cell-signaling cascades (41, 42, 51, 52) . Their effects are different from one cell type to another and likely depend on the expression level of certain type(s) of immunophilin(s) and membrane transporter(s). The data from the present work indicate that CaMK inhibitors and immunosuppressants may serve as useful tools to elucidate some of the steps by which steroid receptors modulate gene transcription.
MATERIALS AND METHODS
Drug Treatment of Cells
Two T47D human breast carcinoma cell lines were used. One cell line was stably transfected with a MMTV-CAT reporter gene (35), while the other contained a synthetic steroidinducible promoter controlling CAT gene expression (GRE 5 tkCAT) (36). Cells were grown in 10-cm Petri dishes in DMEM containing 10% charcoal-treated and heat-inactivated (30 min at 55 C) FBS and 0.2 mg/ml geneticin (G418, Sigma), 24 h before drug and steroid treatment. Hygromycin B (75 g/ml, Boehringer Mannheim, Indianapolis, IN) was used for T47D-GRE 5 cells (36). Immunosuppressive drugs or kinase inhibitors were added for 2 h to the culture medium before steroid exposure when cells were at 50% confluence. Cells were harvested 16 h later, except when noted. CAT enzyme activity was measured in triplicate samples of the cell extracts containing 50 g total protein, as previously described (24, 29) using [ 14 C]chloramphenicol (98 mCi/mmol, ICN, Irvine, CA) as substrate and acetyl coenzyme A as cofactor. All experiments were repeated at least three times. In some experiments, steroids were added 4 h before or at the same time as immunosuppressants or inhibitors. Specific calcium/calmodulin kinase inhibitors KN62 and KN93 as well as H89 and wortmannin (Calbiochem, La Jolla, CA), inhibitors of protein kinase A, and PI 3 kinase, respectively, were also used in other experiments. Ci/mmol, Amersham). A 100-fold excess of radioinert cortisol or Org2058 was added to the incubates to block either glucocorticosteroid or progestin receptor binding in the case of progestins or glucocorticoids labeled cytosol samples, respectively. Portions of cytosol (500 l) were chromatographed on 200 l of packed dihydro-FK506-Affigel 10 or CsA-Affigel 10 columns (1 mg drug/ml gel). To improve FKBP51 binding to FK506-Affigel, 0.15 M NaCl was added to the cytosol sample. Control experiments used non-grafted Affigel-10 resins (Bio-Rad, Richmond, CA). The purification protocol described in Ref. 24 was employed and affinitybound proteins were eluted by exchange (3 ϫ 30 min at 4 C) with 100 l of the appropriate immunosuppressant solution (1 mM) in buffer A.
Immunosuppressant-Affinity Chromatography
Immunoprecipitation Experiments
Cytosol from T47D cells in buffer A, incubated with 3 H-labeled steroid as indicated above was treated with dextrancoated (vol/vol) charcoal (0.5, 5 g/100 ml) for measurement of ligand binding, and 0.5 ml aliquots were incubated (4 h, 4 C) with 10 g of anti-human PR monoclonal antibody mPR1 also named LET126 (73) (Transbio, Paris, France) or MAI140 (Affinity Bioreagents, Neshanic Station, NJ), covalently crosslinked to protein G-Sepharose beads (Pharmacia, Piscataway, NJ), according to the method described in Ref. 74 . Immunopellets containing the same amount of nonimmune IgGs were used as control. For CYP40 and FKBP51 immunoprecipitation, 500 l of cytosol were incubated under the same conditions with 25 l of 638W, a rabbit antiserum against the C-terminal peptide of human CYP40 bound to protein G-Sepharose immunoadsorbent, or 20 g of HI51, a mouse monoclonal anti-FKBP51 efficient in native conditions (14) .
FKBP52 from T47D cell cytosol was immunoprecipitated by the same technique with EC1, a mouse monoclonal antibody specific for mammalian FKBP52 (75) .
After centrifugation (700 ϫ g for 5 min at 0 C), the pellets were washed by two successive centrifugations with 250 l of buffer B (0.1 M potassium phosphate, 10% glycerol, 20 mM sodium tungstate, pH 7.5) and then three times with 250 l of buffer A. The pellets were resuspended in 200 l of Laemmli (76) sample buffer and boiled before denaturing SDS-PAGE and Western blotting experiments. In some experiments, immunoadsorbed proteins were eluted from the immunomatrix by a pH 10.2 buffer two times for 1 h and immediately neutralized by NaH 2 PO 4.
SDS-PAGE and Western Blotting
Samples were resolved on either 10% or 12% SDS-PAGE, according to Laemmli (76) . Western blots were performed as previously described (24) . The nitrocellulose papers were probed with the following antibodies: the mouse monoclonal mPR1 for the detection of the human B form of PR (73) , the mouse monoclonal MA1-140 for the detection of PR-A and PR-B isoforms (77) . EC1 (75) and/or 173, a rabbit polyclonal antipeptide antibody (10), were both used for the detection of FKBP52, 638W (24) (24) . FKBP51 was identified with FF1 (a mouse monoclonal antibody working in denaturing conditions). All the antibodies were used at 10 g Ig/ml, 174 and 638W antisera were used at 1:500 dilution. The detection of the antigen-antibody complexes was performed with a second biotinylated antibody (Vectastain ABC Kit, Vector Laboratories, Burlingame, CA).
When the chemiluminescent detection system (ECL, Amersham Bucks, England) was employed, antibodies were used at 2 g/ml or 1:6000 serum dilution.
Nuclear Receptor Extraction and Sucrose Gradient Analysis
The effects of immunosuppressants upon the size of the heterooligomeric PR were tested after exposure of T47D cells to Rap (10 M) for 2 h before addition of 10 nM [ 3 H]Org 2058. Cells were then harvested and washed three times in PBS, before being homogenized in buffer A (1 vol of buffer A for 1 vol of pelleted cells). The cytosol was obtained as mentioned above. The pellet remaining after cytosol preparation was washed three times with 5 vol of buffer A, before being homogenized in buffer A containing 0.4 M KCl plus 20 mM Na 2 WO 4 (buffer B), as described previously (45) . In these conditions no cytosol contamination is obtained since no lactate dihydrogenase activity can be detected (45) . In particular experiments, whole cells extracts were obtained in buffer B after four freezing steps in liquid nitrogen and subsequent thawing at 20 C. The samples containing [ 3 H]Org 2058-PR complexes were centrifuged for 2 h at 70, 000 rpm in 5-20% sucrose gradients in buffer A containing 20 mM Na 2 WO 4 in a Vti 80 rotor (Beckman) with internal markers GO (glucose oxidase, 7.9S) and PO (peroxidase, 3.6S).
Northern Blot Analysis
RNA from T47D cells exposed to the different drugs was extracted using Trizol reagent (Life Technologies, Gaithersburg, MD) according to the manufacturer's instructions. Total RNA (20 g) of each sample was electrophoresed through a 1% denaturing agarose-formaldehyde gel and transferred to a nylon membrane (Hybond-NX, Amersham). RNAs were cross-linked to the membrane using a X-link apparatus (BioRad, Ilkirch, France) at 0.7 J/cm 2 . The membrane was prehybridized for 6 h in 50% formamide and then hybridized with probes labeled to high specific activity (Ϸ2.10 8 cpm/g) using [␣ 32 P]dCTP by the random primer-labeling procedure (Amersham). Hybridization was carried out at 42 C in 50% formamide containing 5ϫ Denhardts, 1% (wt/vol) SDS, 2ϫ SSPE (225 mM NaCl, 16 mM NaH 2 PO 4, 1.5 mM EDTA, pH 7.4) 0.25 mg/ml salmon sperm DNA (Sigma, St. Louis, MO). The membranes were washed two times in 1ϫ SSC (15 mM NaCl, 1.5 mM sodium citrate, pH 7.0), 0.1% (wt/vol) SDS at room temperature for 20 min, followed by two 20-min washes in 0.1ϫ SSC, 0.1% SDS at 55 C. The dry blot were exposed for 1-3 days at Ϫ80 C to Kodak X-OMAT AR-5 films, using intensifying screens. mRNA was quantitated by densitometry scanning using a Storm apparatus (Molecular Dynamics, Sunnyvale, CA). For Northern blots using Cyclin D1 probe, T47D cells were grown in serum-free DMEM for 48 h, to synchronize them after which the medium was replaced by DMEM containing stripped serum to which drugs had been added.
Radioactivity Counting and Protein Determination
Radioactivity was measured in a Minaxi tricarb (Packard, Downers Grove, IL) spectrometer, and proteins were determined with the BIORAD Kit using BSA as the standard. 
